Aware Super’s West Pharmaceutical WST Stock Holding History

Aware Super’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-61,501	Closed	-$15.4M	–	266
2026 Q1	$15.4M	Buy	+61,501	New	+$15.3M	0.23%	115
2023 Q4	$7.51M	Buy	+27,309	New	+$9.66M	0.1%	160

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aware Super's WST Position: Q2 2026 in Review

Aware Super sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 61,501 shares — an estimated $15.4M sold.

Aware Super first reported a position in WST in Q4 2023 and held it in 2 quarters. The position peaked at $15.4M in Q1 2026. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Aware Super reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Aware Super sold 61,501 West Pharmaceutical shares in Q2 2026, an estimated $15.4M.
Aware Super first reported a position in West Pharmaceutical in Q4 2023 and held it in 2 quarters.
Aware Super's West Pharmaceutical position peaked at $15.4M in Q1 2026.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.